The researchers mentioned that the GST council, in its 56th meeting, recommended the total exemption of 33 lifesaving drugs, including those used in cancer care, from GST altogether (erstwhile 12 per cent to now zero and three critical drugs for rare diseases and cancer from 5 per cent earlier to zero).